Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAvon Protection Regulatory News (AVON)

Share Price Information for Avon Protection (AVON)

Share Price is delayed by 15 minutes
Get Live Data
1,664.00    -4.00 (-0.24%)
Bid:
1,662.00
Ask:
1,668.00
Spread: 6.00 (0.361%)
Market Cap: £490.08m
AVON Live PriceLast checked at - London Stock Exchange

Intraday Avon Protection Share Chart

Director/PDMR Shareholding

29 Nov 2022 14:00

RNS Number : 9679H
Avon Protection PLC
29 November 2022
 

29 November 2022

Avon Protection plc ("the Company")

PDMRs' Interest in Shares

Release of 2020 deferred bonus shares

As previously announced to shareholders on 8 December 2020, a portion of the annual bonus payments due to PDMRs Miles Ingrey-Counter and James Wilcox in respect of the 2020 financial year were deferred into Company shares, to be held for two years.

On 25 November 2022, following expiry of the deferral period, 359 deferred bonus shares were released to Miles Ingrey-Counter and 456 to James Wilcox.

1

Details of person discharging managerial responsibilities/person closely associated

a)

Name

1) Miles Ingrey-Counter

2) James Wilcox

2

Reason for the notification

a)

Position / status

1) Company Secretary

2) Chief Technical Officer

b)

Initial notification /

amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Avon Protection plc

b)

LEI

213800JM1AN62REBWA71

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the

financial instrument

and ISIN Code

Ordinary £1 shares in Avon Protection plc

 

GB0000667013

b)

Nature of the

transaction

Shares released under the 2020 deferred bonus scheme. The shares were purchased on 7 December 2020 for £40.04 and were released following expiry of the 2020 deferral period on 22 November 2022.

c)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

1) Nil

2) Nil

 

1) 359

2) 456

 

d)

Aggregated Information

Aggregated volume

Aggregated price

Aggregated total

 

 

 

815

Nil

Nil

e)

Date of the

transactions

All occurred on 25 November 2022.

 

f)

Place of the

transaction

Outside of a trading venue.

 

 

 

 2022 deferred bonus arrangements

 

A portion of the annual bonus payments due to the Executive Director Rich Cashin and certain PDMRs of the Company in respect of the 2022 financial year were deferred into Company shares on the 25 November 2022. 25% of the annual bonus for the Executive Director, and 25% of the annual bonus linked to financial targets (as distinct from personal performance targets) for the PDMRs, was subject to tax and national insurance/social security and the net amount was used to purchase Company shares. The shares are to be held for two years and are not subject to the Company's shareholding guidelines.

 

The table below sets out the number of 2022 deferred bonus shares held by the Executive Director and each PDMR following this transaction.

 

1

Details of person discharging managerial responsibilities/person closely associated

a)

Name

1) Rich Cashin

2) Miles Ingrey-Counter

3) James Wilcox

4) Steve Genzer

2

Reason for the notification

a)

Position / status

1) Chief Financial Officer

2) Company Secretary

3) Chief Technical Officer

4) Chief Operating Officer

b)

Initial notification /

amendment

Initial notification

 

3

Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

a)

Name

Avon Protection plc

b)

LEI

213800JM1AN62REBWA71

4

Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a)

Description of the

financial instrument

and ISIN Code

Ordinary £1 shares in Avon Protection plc

 

GB0000667013

b)

Nature of the

transaction

Acquisition of shares. 25% of the annual bonus payments for Executive Directors and 25% of the annual bonus payments linked to financial targets (as distinct from personal performance targets) for the PDMRs, was subjected to tax and national insurance/social security and the net amount was used to purchase Company shares. The shares are to be held for two years and are not subject to the Company's shareholding guidelines.

c)

Price(s) and

volume(s)

 

Price(s)

Volume(s)

1) 11.73

2) 11.73

3) 11.73

4) 11.73

1) 1,185

2) 800

3) 849

4) 1,321

 

d)

- Aggregated volume

- Aggregated price

- Aggregated total

 

 

N/A

e)

Date of the

transactions

All occurred on 2022-11-25

 

f)

Place of the

transaction

London Stock Exchange (XLON)

 

 

LEI: 213800JM1AN62REBWA71Classification: Transactions by PDMRs under article 19 of the Market Abuse Regulation.

 

 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
DSHXKLFLLFLEFBZ
Date   Source Headline
12th Jan 20122:00 pmRNSAnnual Information Update
9th Jan 20125:16 pmRNSHolding(s) in Company
4th Jan 20123:45 pmRNSHolding(s) in Company
3rd Jan 201212:00 pmRNSHolding(s) in Company
20th Dec 20113:32 pmRNSAnnual Financial Report
20th Dec 20113:30 pmRNSDirector/PDMR Shareholding
20th Dec 20119:45 amRNSFilter Contract Award
2nd Dec 201111:40 amRNSEmployee Share Plans
28th Nov 20115:10 pmRNSHolding(s) in Company
23rd Nov 20117:00 amRNSFinal Results
16th Nov 20115:41 pmRNSHolding(s) in Company
16th Nov 20113:38 pmRNSHolding(s) in Company
10th Oct 20117:00 amRNSFull Year Trading Update
7th Sep 20115:45 pmRNSHolding(s) in Company
2nd Sep 20114:10 pmRNSHolding(s) in Company
18th Aug 20117:00 amRNSInterim Management Statement
10th Aug 20117:00 amRNSHolding(s) in Company
8th Aug 20117:00 amRNSUS Department of Defense contract award
20th Jul 201110:06 amRNSHolding(s) in Company
23rd Jun 20114:30 pmRNSHolding(s) in Company
21st Jun 20114:39 pmRNSHolding(s) in Company
21st Jun 201110:49 amRNSHolding(s) in Company
21st Jun 201110:45 amRNSHolding(s) in Company
17th Jun 20113:33 pmRNSHolding(s) in Company
16th Jun 20114:09 pmRNSHolding(s) in Company
15th Jun 201111:19 amRNSHolding(s) in Company
7th Jun 20117:00 amRNSDirector/PDMR Shareholding
23rd May 20113:40 pmRNSDirector/PDMR Shareholding
13th May 20112:24 pmRNSHolding(s) in Company
4th May 20117:00 amRNSHalf Yearly Report
12th Apr 20119:45 amRNSNotice of Results
28th Mar 20115:34 pmRNSDirector/PDMR Shareholding
25th Mar 20114:52 pmRNSHolding(s) in Company
3rd Mar 20114:02 pmRNSResult of AGM
11th Feb 201110:30 amRNSDirector/PDMR Shareholding
8th Feb 20119:00 amRNSBlocklisting Interim Review
28th Jan 20119:15 amRNSHolding(s) in Company
28th Jan 20119:15 amRNSDirector/PDMR Shareholding
25th Jan 20117:00 amRNSInterim Management Statement
17th Jan 20119:00 amRNSAnnual Information Update
7th Jan 201111:00 amRNSAnnual Financial Report
3rd Dec 20103:24 pmRNSEmployee Share Plans
30th Nov 20102:49 pmRNSHolding(s) in Company
30th Nov 201010:12 amRNSHolding(s) in Company
29th Nov 20108:27 amRNSHolding(s) in Company
24th Nov 20107:00 amRNSFinal Results
11th Oct 20107:00 amRNSYear-end Update
1st Oct 20103:38 pmRNSHolding(s) in Company
1st Oct 20103:35 pmRNSHolding(s) in Company
1st Oct 20103:33 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.